Clinical Trials Browser

Completed × eribulin × CNS × Clear all

NCT02338037 2024-03-19

Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors

Phase EARLY_PHASE1 Completed

Brain Neoplasms

NCT02581839 2020-07-30

Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate

Phase 2 Completed

9 enrolled 14 charts

Brain Neoplasms, Breast Neoplasms